Video Latest - ecancer

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany

11 Dec 2014

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Dr William Sikov - Women and Infants Hospital, Providence, USA

11 Dec 2014

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany

11 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele

8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger

8 Dec 2014

Busulfan exposure dose tested for MDS and AML

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

Combination therapy for high-risk MDS? Not quite yet

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA

8 Dec 2014

Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy

8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule

8 Dec 2014

ASH 2014: Highlights in multiple myeloma

Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios Dimopoulos

8 Dec 2014

Tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia

Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany

7 Dec 2014

New cytarabine combinations could overcome toxicities in AML treatment

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

7 Dec 2014

Video